Core Viewpoint - McKesson reported quarterly earnings of $8.26 per share, exceeding the Zacks Consensus Estimate of $8.23 per share, and showing an increase from $7.88 per share a year ago, indicating a positive earnings surprise of +0.36% [1][2] Financial Performance - The company achieved revenues of $97.83 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 1.82%, and up from $79.28 billion in the same quarter last year [2] - Over the last four quarters, McKesson has exceeded consensus EPS estimates three times and topped revenue estimates two times [2] Stock Performance - McKesson shares have increased approximately 24.5% since the beginning of the year, significantly outperforming the S&P 500's gain of 7.1% [3] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $8.61 for the coming quarter and $37.26 for the current fiscal year, alongside projected revenues of $103.81 billion and $406.16 billion respectively [7] - The Zacks Rank for McKesson is currently 2 (Buy), indicating expectations for the stock to outperform the market in the near future [6] Industry Context - The Medical - Dental Supplies industry, to which McKesson belongs, is currently in the top 25% of over 250 Zacks industries, suggesting a favorable environment for stock performance [8]